| 000 | 01322 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515004550.0 | ||
| 264 | 0 | _c20051122 | |
| 008 | 200511s 0 0 eng d | ||
| 022 | _a0231-424X | ||
| 024 | 7 |
_a10.1556/APhysiol.92.2005.2.2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCsászár, A | |
| 245 | 0 | 0 |
_aHypertriglyceridemia, the coronary heart disease risk marker "solved". _h[electronic resource] |
| 260 |
_bActa physiologica Hungarica _c2005 |
||
| 300 |
_a109-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aApolipoprotein C-III |
| 650 | 0 | 4 |
_aApolipoproteins C _xphysiology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aClofibric Acid _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Disease _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperinsulinism _xdrug therapy |
| 650 | 0 | 4 |
_aHypertriglyceridemia _xcomplications |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aLipoproteins _xmetabolism |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xphysiology |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xphysiology |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 773 | 0 |
_tActa physiologica Hungarica _gvol. 92 _gno. 2 _gp. 109-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1556/APhysiol.92.2005.2.2 _zAvailable from publisher's website |
| 999 |
_c15893482 _d15893482 |
||